These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35131974)

  • 1. Routine Catheter Lock Solutions in Pediatric Cancer Care: A Pilot Randomized Controlled Trial of Heparin vs Saline.
    Ullman AJ; Edwards R; Walker R; Roy J; Paton A; Rickard CM; Cooke M; Bradford N; Gibson V; Cattanach P; Paterson RS; Takashima M; Byrnes J; Keogh S; Kleidon T
    Cancer Nurs; 2022 Nov-Dec 01; 45(6):438-446. PubMed ID: 35131974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial).
    Ullman A; Takashima M; Gibson V; Comber E; Borello E; Bradford N; Byrnes J; Cole R; Eisenstat D; Henson N; Howard P; Irwin A; Keogh S; Kleidon T; Martin M; McCleary K; McLean J; Moloney S; Monagle P; Moore A; Newall F; Noyes M; Rowan G; St John A; Wood A; Wolf J; Ware R
    BMJ Open; 2024 Jul; 14(7):e085637. PubMed ID: 38986559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Central Venous Access Device Lock Solutions: A Network Meta-analysis.
    Takashima M; Ezure Y; Furuya-Kanamori L; Wolf J; Dufficy M; Gibson V; Clark J; Ullman A
    Pediatrics; 2024 Jan; 153(2):. PubMed ID: 38287882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial.
    Ullman AJ; Kleidon T; Gibson V; McBride CA; Mihala G; Cooke M; Rickard CM
    BMC Cancer; 2017 Aug; 17(1):595. PubMed ID: 28854967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central venous Access device SeCurement And Dressing Effectiveness (CASCADE) in paediatrics: protocol for pilot randomised controlled trials.
    Ullman AJ; Kleidon T; Gibson V; Long DA; Williams T; McBride CA; Hallahan A; Mihala G; Cooke M; Rickard CM
    BMJ Open; 2016 Jun; 6(6):e011197. PubMed ID: 27259529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population.
    Ornowska M; Wong H; Ouyang Y; Mitra A; White A; Willems S; Wittmann J; Reynolds S
    Trials; 2022 Aug; 23(1):719. PubMed ID: 36042488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central venous access device adverse events in pediatric patients with cancer: a systematic review and meta-analysis.
    Nunn JL; Takashima MD; Wray-Jones EM; Soosay Raj TA; Hanna DMT; Ullman AJ
    Support Care Cancer; 2024 Sep; 32(10):662. PubMed ID: 39283363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric central venous access devices: practice, performance, and costs.
    Ullman AJ; Gibson V; Takashima MD; Kleidon TM; Schults J; Saiyed M; Cattanach P; Paterson R; Cooke M; Rickard CM; Byrnes J; Chopra V
    Pediatr Res; 2022 Nov; 92(5):1381-1390. PubMed ID: 35136199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central venous access device Securement and dressing effectiveness: The CASCADE pilot randomised controlled trial in the adult intensive care.
    Mitchell ML; Ullman AJ; Takashima M; Davis C; Mihala G; Powell M; Gibson V; Zhang L; Bauer M; Geoffrey Playford E; Rickard CM
    Aust Crit Care; 2020 Sep; 33(5):441-451. PubMed ID: 31757717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter lock solutions to prevent CVAD-related infection.
    Gabriel JA
    Br J Nurs; 2020 Feb; 29(3):S25-S29. PubMed ID: 32053448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter-associated bloodstream infections in adults with cancer: a prospective randomized controlled trial.
    Mollee P; Okano S; Abro E; Looke D; Kennedy G; Harper J; Clouston J; Van Kuilenburg R; Geary A; Joubert W; Eastgate M; Jones M
    J Hosp Infect; 2020 Oct; 106(2):335-342. PubMed ID: 32712388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CATERPILLAR study: an assessor-blinded randomized controlled trial comparing a taurolidine-citrate-heparin lock solution to a heparin-only lock solution for the prevention of central-line-associated bloodstream infections in paediatric oncology patients.
    van den Bosch CH; Loeffen YGT; van der Steeg AFW; van der Bruggen JT; Frakking FNJ; Fiocco M; van de Ven CP; Wijnen MHWA; van de Wetering MD
    J Hosp Infect; 2024 Oct; 152():56-65. PubMed ID: 39004189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
    Wouters Y; Roosenboom B; Causevic E; Kievit W; Groenewoud H; Wanten GJA
    Clin Nutr; 2019 Oct; 38(5):2210-2218. PubMed ID: 30292482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation in Central Venous Access Device Security: A Pilot Randomized Controlled Trial in Pediatric Critical Care.
    Ullman AJ; Long D; Williams T; Pearson K; Mihala G; Mattke AC; Macfarlane F; Rickard CM
    Pediatr Crit Care Med; 2019 Oct; 20(10):e480-e488. PubMed ID: 31274778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central venous access device-related infections in patients with haemophilia.
    Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
    J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
    Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
    Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Road map for improvement: Point prevalence audit and survey of central venous access devices in paediatric acute care.
    Ullman AJ; Cooke M; Kleidon T; Rickard CM
    J Paediatr Child Health; 2017 Feb; 53(2):123-130. PubMed ID: 27709723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study.
    van den Bosch CH; van der Bruggen JT; Frakking FNJ; Terwisscha van Scheltinga CEJ; van de Ven CP; van Grotel M; Wellens LM; Loeffen YGT; Fiocco M; Wijnen MHWA
    J Pediatr Surg; 2019 Sep; 54(9):1894-1900. PubMed ID: 30415957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of occlusion of cEnTral lInes for children with cancer: An implementation study.
    Ullman AJ; Condon P; Edwards R; Gibson V; Takashima M; Schults J; Dean A; Cattanach P; Nicholls W; Osborne S; Rickard CM; Cooke M; Kleidon T
    J Paediatr Child Health; 2020 Dec; 56(12):1875-1884. PubMed ID: 32808404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
    van den Bosch CH; Loeffen Y; van der Steeg AFW; van der Bruggen JT; Frakking FNJ; Fiocco M; van de Ven CP; Wijnen MHWA; van de Wetering MD
    BMJ Open; 2023 Mar; 13(3):e069760. PubMed ID: 36944461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.